Scott Kopetz
MD, PhD
Professor of GI Medical Oncology
👥Biography 个人简介
Scott Kopetz is a leading CRC researcher who has driven major advances in molecularly targeted therapy, particularly for BRAF-mutant CRC. His BEACON trial established the encorafenib-cetuximab combination as standard of care for BRAF V600E-mutant CRC. He is a pioneer in integrating comprehensive molecular profiling with immunotherapy strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Scott Kopetz 的研究动态
Follow Scott Kopetz's research updates
留下邮箱，当我们发布与 Scott Kopetz（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment